UC San Francisco (Audio‪)‬ UCTV

As part of the 2024 Developmental Disabilities Conference, Vivian Huan, Senior Policy Attorney of Disability Rights California, presents key findings and recommendations regarding racial disparities in access to services and funding in California for people in the developmental disability system. After investments were made to reduce disparities, they worsened. Huan presents strategies that may work moving forward. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 39741]

As part of the 2024 Developmental Disabilities Conference, Dr. Megumi Okumura, Medical Director of the newly established UCSF Health Pediatric to Adult Transitions Program, describes a roadmap for health care transition, the process of moving from a child/family centered to an adult/patient centered model of health care; and introduces tools from a recently updated Got Transition, a collaborative effort by the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Physicians. She emphasizes the need to begin the transition process early and the importance of patients, caregivers, clinicians and agencies to work together to address barriers and to assure effective transition and transfer of care. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 39749]

As part of the 2024 Prostate Cancer Patient Conference, Drs. Julian Hong and Eric Small discuss oligometastatic prostate cancer and its management with radiation and systemic therapies.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39766]

As part of the 2024 Prostate Cancer Patient Conference, patient advocate Stan Rosenfeld leads a panel discussion including Dr. Benjamin Breyer, patients, and their partners, on living with prostate cancer.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39773]

As part of the 2024 Prostate Cancer Patient Conference, Dr. Rahul Aggarwal reviews emerging treatment approaches for advanced prostate cancer, including developments for antibody-drug conjugates, immunotherapy (T cell engagers), targeted radiation, and targeting Androgen Receptor Signaling.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39772]

As part of the 2024 Developmental Disabilities Conference, Dr. Peter Kang, Professor of Genetics at the University of Minnesota, presents a detailed summary of recent advances in gene therapy for children with neuromuscular disorders, specifically Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, and Pompe Disease. He uses case studies to demonstrate diagnostic dilemmas, intricacies of developing and delivering treatment, and the importance of shared decision making about therapies with families. Series: "Developmental Disabilities Update" [Health and Medicine] [Show ID: 39747]